May P R, Van Putten T, Yale C, Potepan P, Jenden D J, Fairchild M D, Goldstein M J, Dixon W J
J Nerv Ment Dis. 1976 Mar;162(3):177-83. doi: 10.1097/00005053-197603000-00004.
The literature and the findings from the Camarillo Schizophrenia Research Project reported in this paper indicate that a satisfactory method for predicting the response of an individual schizophrenic patient to antipsychotic drugs has yet to be devised. A test dose procedure is described which offers promise of a practical approach to selecting the most appropriate drug and dosage for a particular patient and tailoring blood concentrations to the needs of the individual case. Preliminary findings indicate that the test dose procedure is feasible; that detectable changes occur after a single test dose; and that measurements made during the test dose period may be predictive of eventual outcome. These findings are, of course, only a report of a preliminary pilot experiment, subject to important caveats about small number of cases, interpretation of large numbers of correlation coefficients, and need for cross-validation. Nevertheless, they are encouraging and suggest that the test dose approach has considerable potential for further research.
本文所报道的文献及卡马里洛精神分裂症研究项目的研究结果表明,尚未设计出一种令人满意的方法来预测个体精神分裂症患者对抗精神病药物的反应。本文描述了一种试验剂量程序,该程序有望为为特定患者选择最合适的药物和剂量以及根据个体情况调整血药浓度提供一种实用方法。初步研究结果表明,试验剂量程序是可行的;单次试验剂量后会出现可检测到的变化;并且在试验剂量期间进行的测量可能预测最终结果。当然,这些发现只是一项初步试点实验的报告,存在关于病例数量少、大量相关系数的解释以及交叉验证需求等重要限制条件。尽管如此,它们还是令人鼓舞的,并表明试验剂量方法具有很大的进一步研究潜力。